» Articles » PMID: 24105671

What Are the Criteria for Terminating Treatment for Necrotizing (malignant) Otitis Externa?

Overview
Journal Laryngoscope
Date 2013 Oct 10
PMID 24105671
Citations 21
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evaluation of the clinical and radiological features of patients with Malignant otitis externa (MOE).

Tabashiri A, Allahverdi Nazhand H, Fathy M, Mortazavi S, Javandoust Gharehbagh F, Haghighi-Morad M BMC Infect Dis. 2025; 25(1):277.

PMID: 40000962 PMC: 11863464. DOI: 10.1186/s12879-025-10637-8.


Skull base osteomyelitis: HBO as a therapeutic concept Effects on clinical and radiological results.

Simon M, Dreyer S, Joost I, Rubbert C, Schipper J, Kristin J Eur Arch Otorhinolaryngol. 2024; .

PMID: 39613850 DOI: 10.1007/s00405-024-09081-2.


Head-to-Head Comparison Between F-FDG PET and Leukocyte Scintigraphy to Monitor Treatment Responses in Necrotizing Otitis Externa.

Hurstel M, Vasseur A, Melki S, Veran N, Imbert L, Nguyen D J Otolaryngol Head Neck Surg. 2024; 53:19160216241288810.

PMID: 39417996 PMC: 11487542. DOI: 10.1177/19160216241288810.


Exploring the OTITIS Research Landscape Through a Scientometric Approach.

Akhlaghi A, Hashemi S, Hamidi A, Khosravi A, Jahangiri R Indian J Otolaryngol Head Neck Surg. 2024; 76(2):1697-1710.

PMID: 38566640 PMC: 10982269. DOI: 10.1007/s12070-023-04387-9.


Management and Outcomes of Necrotizing Otitis Externa: A Retrospective Cohort Study in a Tertiary Referral Center.

Vosbeek E, Straatman L, Braat A, de Keizer B, Thomeer H, Smit A Otol Neurotol Open. 2024; 3(4):e042.

PMID: 38516544 PMC: 10950167. DOI: 10.1097/ONO.0000000000000042.